BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AGAH - ECPv5.16.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AGAH
X-ORIGINAL-URL:https://dev.agah.eu
X-WR-CALDESC:Veranstaltungen für AGAH
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20161030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160421
DTEND;VALUE=DATE:20160423
DTSTAMP:20260929T023945
CREATED:20190214T203207Z
LAST-MODIFIED:20190607T071351Z
UID:1036-1461196800-1461369599@dev.agah.eu
SUMMARY:25th AGAH Annual Meeting 2016
DESCRIPTION:The immune system is an important target in medicines development. Effective drugs against cancer\, viral and bacterial infections or autoimmune diseases have entered the clinic; immunotherapy of cancer was even claimed to be the imminent break­through of the year in 2013. \nImmunotherapy is the main topic of the upcoming annual meeting of the AGAH. The conference will start with an overview about how to define different approaches and will present an insight into current and future therapeutic opportunities. With respect to early medicines development\, the conference will focus on special requirements regarding the development of medicines in this field. \nThe annual congress offers a one-day pre-meeting workshop about the basics of immunology. This workshop will be held by experts and is designed to teach the basic principles and functions of the immune system starting from scratch. The workshop is the ideal preparation for the annual meeting for those who are not yet experts in the field. \nAs this is the 25th anniversary of the AGAH we are looking forward to celebrating this event with you and are happy to wel­come you to Berlin. \nThe Board of the AGAH e.V. \n\n\n\n	Title\nExploratory drug development in immunological therapy – from in vitro pharmacology to early patient trials\n \n\n\n\n	Venue\nKaiserin Friedrich Haus\nRobert-Koch-Platz 7\n10115 Berlin\nPhone: 030 / 30888928\n \n\n\n\n	Date \nWednesday\, 20th April 2016 (General Assembly)\nThursday\, 21st April 2016\nFriday\, 22nd April 2016\n \n\n\n\n	Conference office \nCSi Hamburg GmbH\nJungfrauenthal 22\, D-20149 Hamburg\nPhone: +49 40 30770 300\nFax: +49 40 30770 301\nE-Mail: agah-veranstaltungen@csihamburg.de\n \n\n\n\n	Fees \n\nWorkshop “Basic principles of immunology” 20 April 2016 \n\n\n\nMember\n150 EUR\n\n\nNon-Member\n180 EUR\n\n\n\nAGAH Annual Meeting 2016 „Exploratory drug development in immunotherapy“\, 21 to 22 April 2016 (early bird until January 31\, 2016) \n\n\n\n\nearly bird\nregular\n\n\n\n\nMember*\n300 EUR\n350 EUR\n\n\nNon-Member\n380 EUR\n450 EUR\n\n\nJunior Scientists (under age 30)\n150 EUR\n250 EUR\n\n\nDay Ticket\n\n250 EUR\n\n\nConference-Networking-Dinner\n50 EUR\n50 EUR\n\n\n\n\n\n\n\n	Language \nEnglisch\n \n\n\n\n	Programme Committee \nK. Breithaupt-Grögler\, C. Coch\, K. Erb-Zohar\, S. Klammt\, J. Rengelshausen\, B. Schug\, H. Sourgens\, J. Täubel\n \n\n\n\n	Day 1: Wednesday\, 20th April 2016 \nWorkshop: Basic principles of immunology – a training course\nChairs: C. Coch\, M. Coenen \n13:00 – 14:30 \nThe innate immune system (pathogen-associated molecular patterns (PAMPs)\, phagocytes\, etc.)\nW. Barchet\, Bonn  \n\n14:30 – 15:00 \nBreak \n\n15:00 – 16:30\nThe adaptive immune system (antibodies\, T cells\, etc.)\nD. Wohlleber\, München  \n\n16:30 – 17:00 \nBreak \n\n17:00 – 18:00 \nThe immune system as a therapeutic target / tool – examples from rheumatology\nT. Dörner\, Berlin  \n\n18:30\n Get together \n\nSession 2: Drug-induced liver injury \nChairs: S. Plassmann\, Munich (Germany); G. Wensing\, Wuppertal (Germany) \n\n19:00 	 \n	AGAH General Assembly (Mitgliederversammlung) \n\n\n\n\n\n	Day 2: Thursday\, 21st April 2016 \n08:45 \nWelcome and opening remarks \nH. Sourgens\, München \n\n09:00 – 09:45 \nImmunotherapy – a growing field\nD. Wolf\, Bonn \n\nSession 1: Suppressing mechanisms in immunotherapy\nChairs: H. Sourgens\, D. Wolf \n\n09:45 – 10:15\nBeyond aspirin – new anti-inflammatory therapy for atherosclerosis\nS. Zimmer\, Bonn \n\n10:15 – 10:45\nNovel immune targets for monoclonal antibodies\nC.Burkhart\, Novartis  \n\n10:45 – 11:15 \nInduction of transplantation tolerance\nB. Sawitzki\, Berlin \n\n11:15 – 11:45\nBreak \n\nSession 2: Modulating mechanisms in immunotherapy\nChairs: J. Taeubel\, H. Stauss \n\n11:45 – 12:15\nModern immune and gene therapy of immunodeficiencies\nM. Witzel\, München \n\n12:15 – 12:45\nAll is well that ends well – Fc part and design of immunoglobulins \nI. Schwab\, Erlangen \n\n12:45 – 13:15\nDesigning the killer – CAR T cells in the treatment of tumour\nH. Stauss\, London \n\n13:15 – 14:15\nBreak \n\n\nSession 3: Activating mechanisms in immunotherapy\nChairs: J. Rengelshausen\, C. Coch \n\n14:15 – 14:45\nActivation of the innate immune receptor RIG-I as novel target in the treatment of tumours and infectious diseases \nC. Coch\, Bonn  \n\n14:45 – 15:15\nInhibit the inhibitor – immune-checkpoint inhibitors in the treatment of tumors\nA. Letsch\, Berlin \n\n15:15 – 15:45\nDose finding and patient selection in the development of immunotherapies: the case of immune-checkpoint inhibitors \nJ. Theis\, Frankenforst \n\n15:45 – 16:15\nBreak \n\nSession 4: Immunotoxicity / Immunogenicity\nChairs: C. Meisel\, K. Erb-Zohar \n\n16:15 – 16:45\nHow to monitor immunotoxicity in novel immunological therapies?\nC. Meisel\, Berlin \n\n16:45 – 17:15\nHow to monitor immunogenicity in novel immunological therapies?\nA. Kromminga\, Hamburg \n\n19:30\nConference Dinner \n\n\n\n\n\n	Day 3: Friday\, 22nd April 2016 \nSession 5: Early trials with vaccines\nChairs: B. Ziegele\, B. Schug \n\n09:00 – 09:30\nDesign and specific aspects of early clinical trials with novel vaccines\nS.Yuansheng\, Langen \n\n09:30 – 10:00\nTumor vaccines – where do we come from? Where do we go?\nF. A. Ossendorp\, Leiden \n\n10:00 – 10:30\nExperience of vaccine development against ebola virus\nC. Dahlke\, Hamburg \n\n10:30 – 11:00\nBreak \n\nSession 6: Challenges in immunotherapy – what did we learn?\nChairs: H. Sourgens\, K. Breithaupt \n\n11:00 – 11:30\nC5 inhibition and the associated recommended vaccine prophylaxis\nJ. Täubel\, London \n\n11:30 – 12:00\nAfter the storm: the return of the CD28 superagonist TGN1412/TAB08 to clinical development.\nT. Hünig\, Würzburg \n\n12:00 – 12:30\nHas MABEL kept the promise? – 10 years of experience\nB. Klug\, Langen \n\n12:30 – 13:00\nRound table discussion \n\n13:00\nConcluding remarks\nB. Schug \n\n13:15\nFarewell lunch \n\n\n\n\n\n	Speaker / Chairs \n\n\nProf. Dr. Winfried Barchet\nUniversitätsklinikum Bonn\nDr. Kerstin Breithaupt-Grögler\n-kbr- clinical pharmacology services\, Frankfurt a.M.\nDr. Christian Burkhart\nNovartis Pharma AG\, Basel\nDr. Christoph Coch\nUniversitätsklinikum Bonn\nDr. Martin Coenen\nUniversitätsklinikum Bonn\nDr. Christine Dahlke\nUniversitätsklinikum Hamburg-Eppendorf\nProf. Dr. Thomas Dörner\nCharité Berlin\nDr. Katharina Erb-Zohar\nclinphase®\, Hanau\nProf. Dr. Thomas Hünig\nUniversität Würzburg\nProf. Dr. Arno Kromminga\nIPM Biotech GmbH\, Hamburg\nDr. Bettina Klug\nPaul-Ehrlich-Institut\, Langen\nPD Dr. Anne Letsch\nCharité Berlin\nDr. Christian Meisel\nLabor Berlin – Charité Vivantes GmbH\, Berlin\nProf. Dr. Ferry A. Ossendorp\nLeiden Univercity Medical Center\, &Leiden NL\nDr. Jens Rengelshausen\nGrünenthal GmbH\nProf. Dr. Birgit Sawitzki\nCharité Berlin\nMs Inessa Schwab\nUniversität Erlangen-Lehrstuhl Genetik\nDr. Barbara Schug\nSocraTec R&D GmbH\, Oberursel\nProf. Dr. Hildegard Sourgens\nConsultant\, München\nProf. Dr. Hans Stauss\nUniversity College London\nDr. Jörg Täubel\nRichmond Pharmacology Limited\, London\nProf. Dr. Jochen Theis\nInHeCon – Biotechnology \, Bergisch-Gladbach\nDr. Maximilian Witzel\nKinderklinik und Kinderpoliklinik der LMU München\nDr. Dirk Wohlleber\nInstitut für Molekulare Immunologie und Experimentelle Onkologie\, München\nProf. Dr. Dominik Wolf\nUniversitätsklinikum Bonn\nDr. Sun Yuansheng\nPaul-Ehrlich-Institut\, Langen\nMs Bettina Ziegele\nPaul-Ehrlich-Institut\, Langen\nDr. Sebastian Zimmer\nUniversitätsklinikum Bonn\n\n\n\n\n\n  \n\n\n\n\n	Online Registration\nwww.csioffice.de/secure/conreg_agah2016/registration\n\n\n\n	Downloads\n\nImmunological Aspects in the Non-Clinical Safety Assessment of Drugs in Development \n\nStephanie Plassmann\n\n\n\nHas MABEL kept the promise?\n\nBettina Klug\n\n\n\nExperience of vaccine development against Ebola virus \n\nChristine Dahlke\n\n\n\nInduction of tolerance to allogeneic transplants – from preclinical models to clinical translation \n\nBirgit Sawitzki\n\n\n\n 
URL:https://dev.agah.eu/event/25th-agah-annual-meeting-2016-in-berlin-germany/
LOCATION:Annual Meeting 2016\, Berlin\, Deutschland
CATEGORIES:Jahrestreffen
END:VEVENT
END:VCALENDAR